Key facts
- Laclarée’s last known valuation is $3.7M (Nov 2019).
- It has raised $5.8M; the latest was Accelerator/Incubator in Apr 2026.
- Notable investors include Bpifrance, European Innovation Council, High-Tech Gründerfonds, UI Investissement, ENS (Scientific) — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Laclarée
- ·The full record, as it builds
Funding rounds
No funding rounds for Laclarée are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Laclarée
Manufacturer of adaptive eyeglasses intended for users having presbyopia correction. The company's product uses fluid technology to develop electronic glasses for presbyopia people combining adaptive lens technology including refractive correction lenses for astigmatism, myopia, or hyperopia, enabling users to see clearly and who are not satisfied by progressive lenses or multiple pairs.
- Sector
- Healthcare
- HQ
- Lyon, France
- Founded
- 2016
- Employees
- 12
- Website
- laclaree-vision.com/
- Ownership
- Privately Held (backing)
Laclarée doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Laclarée shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Laclarée in its N-PORT filings yet. We sweep new filings monthly.